Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Riecken, Kristoffer  [Clear All Filters]
2024
Seifert L, Riecken K, Zahner G, Hambach J, Hagenstein J, Dubberke G, Huber TB, Koch-Nolte F, Fehse B, Tomas NM. An antigen-specific chimeric autoantibody receptor NK cell strategy for the elimination of anti-PLA2R1 and anti-THSD7A antibody-secreting cells. Kidney Int. 2024.
Haider M-T, Freytag V, Krause L, Spethmann T, Gosau T, Beine MC, Knies C, Schröder-Schwarz J, Horn M, Riecken K, et al. Comparison of ex vivo bioluminescence imaging, Alu-qPCR and histology for the quantification of spontaneous lung and bone metastases in subcutaneous xenograft mouse models. Clin Exp Metastasis. 2024.
2023
Iaconis D, Caccuri F, Manelfi C, Talarico C, Bugatti A, Filippini F, Zani A, Novelli R, Kuzikov M, Ellinger B, et al. DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action. Viruses. 2023;15(5).
Starzonek S, Maar H, Mereiter S, Freytag V, Haider M-T, Riecken K, Huang Y-L, Jacob F, Wicklein D, Schumacher U, et al. Identification of potential classes of glycoligands mediating dynamic endothelial adhesion of human tumor cells. Glycobiology. 2023.
Tintelnot J, Xu Y, Lesker TR, Schönlein M, Konczalla L, Giannou AD, Pelczar P, Kylies D, Puelles VG, Bielecka AA, et al. Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature. 2023.
Genduso S, Freytag V, Schetler D, Kirchner L, Schiecke A, Maar H, Wicklein D, Gebauer F, Bröker K, Stürken C, et al. Tumor cell integrin β4 and tumor stroma E-/P-selectin cooperatively regulate tumor growth in vivo. J Hematol Oncol. 2023;16(1):23.
2022
Engelmann J, Zarrer J, Gensch V, Riecken K, Berenbrok N, Luu TVinh, Beitzen-Heineke A, Vargas-Delgado MElena, Pantel K, Bokemeyer C, et al. Regulation of bone homeostasis by MERTK and TYRO3. Nat Commun. 2022;13(1):7689.
2020
Kempski J, Giannou AD, Riecken K, Zhao L, Steglich B, Lücke J, Garcia-Perez L, Karstens K-F, Wöstemeier A, Nawrocki M, et al. IL22BP Mediates the Anti-Tumor Effects of Lymphotoxin Against Colorectal Tumors in Mice and Humans. Gastroenterology. 2020.
Möller J, Rosenberg M, Riecken K, Pörtner R, Zeng A-P, Jandt U. Quantification of the dynamics of population heterogeneities in CHO cultures with stably integrated fluorescent markers. Anal Bioanal Chem. 2020.
Lange T, Samatov TR, Galatenko VV, Steffen P, von Kriegstein H, Spethmann T, Wicklein D, Maar H, Kupfernagel K, Labitzky V, et al. Xenograft-derived mRNA/miR and protein interaction networks of systemic dissemination in human prostate cancer. Eur J Cancer. 2020;137:93-107.
2019
Schulze ML, Lemoine MD, Fischer AW, Scherschel K, David R, Riecken K, Hansen A, Eschenhagen T, Ulmer BM. Dissecting hiPSC-CM pacemaker function in a cardiac organoid model. Biomaterials. 2019;206:133-145.
2016
Hossain JA, Ystaas LRømo, Mrdalj J, Välk K, Riecken K, Fehse B, Bjerkvig R, Grønli J, Miletic H. Lentiviral HSV-Tk.007 mediated suicide gene therapy is not toxic for normal brain cells. J Gene Med. 2016.
2015
Ben-Batalla I, Cubas-Cordova M, Udonta F, Wroblewski M, Waizenegger JS, Janning M, Sawall S, Gensch V, Zhao L, Martinez-Zubiaurre I, et al. Cyclooxygenase-2 blockade can improve efficacy of VEGF-targeting drugs. Oncotarget. 2015;6(8):6341-6358.
Wellbrock J, Latuske E, Köhler J, Wagner K, Stamm H, Vettorazzi E, Vohwinkel G, Klokow M, Kühling-Thees R, Ehm P, et al. Expression of Hedgehog pathway mediator GLI represents a negative prognostic marker in human acute myeloid leukemia and its inhibition exerts anti-leukemic effects. Clin Cancer Res. 2015.
Nikitenko NA, Speiseder T, Groitl P, Spirin PV, Prokofjeva MM, Lebedev TD, Rubtsov PM, Lam E, Riecken K, Fehse B, et al. Targeting species D adenoviruses replication to counteract the epidemic keratoconjunctivitis. Biochimie. 2015.
2014
Gomez-Nicola D, Riecken K, Fehse B, V Perry H. In-vivo RGB marking and multicolour single-cell tracking in the adult brain. Sci Rep. 2014;4:7520.
2013
Jung G, Sun J, Petrowitz B, Riecken K, Kruszewski K, Jankowiak W, Kunst F, Skevas C, Richard G, Fehse B, et al. Genetically Modified Neural Stem Cells for a Local and Sustained Delivery of Neuroprotective Factors to the Dystrophic Mouse Retina. Stem Cells Transl Med. 2013.